RxGuardian Inc.
Edric Engert is a seasoned professional with extensive experience in venture capital, business development, and strategic leadership across various industries including life sciences and pharmaceuticals. Currently serving as a Venture Partner at Social Impact Capital, Edric specializes in early investments in disruptive innovations. Additional roles include advising at Bodidata, Inc. on capital raises, and holding executive positions at RxGuardian Inc. and UPNDO focused on commercialization and wellness initiatives, respectively. Edric has also been Managing Director at Abraxeolus Consulting since 2005, providing strategic expertise to a diverse clientele. Previous positions include senior leadership roles at Teva Pharmaceuticals and Sandoz, and engagement management at McKinsey & Company. Edric's education includes a BS in Mathematics from MIT, an MBA from the Wharton School, a diploma in Clarinet from The Juilliard School, and an Advanced Level 3 Certificate in Oenology from the Wine & Spirit Education Trust.
This person is not in any teams
RxGuardian Inc.
RxGuardian Inc. Keeps People Safe. Our tamper-evident abuse-deterrent technologies help prevent Diversion and Substance Use Disorders at the source. RxGuardian Inc. provides supply-side interventions that are easy and inexpensive to implement, including: Safer Lock: patented combination locking products including a locking pill bottle and locking medicine box. Rx Locking Cap: a patented combination cap that fits over standard pharmaceutical vials. RxGuardian Inc.’s product portfolio is available online, through our retail partners and as an insurance benefit.